Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

NCT00620061 ↗

Phase 3 Completed 439 enrolled Sucampo Pharma Americas, LLC

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.

Timeline

Start: 2007-12
Primary completion: 2009-09
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lubiprostone	Small molecule	24 ug	Oral

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Summary

Timeline

Drugs

Indications